박테리오파지 요법 시장 : 표적 세균별, 적응 질환별, 투여 경로별, 유통 채널별, 지역별
Bacteriophage Therapy Market, By Targeted Bacteria, Disease Indication (Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, & Other), Route of Administration, Distribution Channel & Geography
상품코드
:
1357951
리서치사
:
Coherent Market Insights
발행일
:
2023년 09월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 박테리오파지 요법 시장은 2023년에는 12억 8,090만 달러에 달할 것으로 추정되며, 예측 기간 중(2023-20301년) 3.7%의 CAGR을 보일 것으로 예측됩니다.
| 리포트 대상 범위 |
리포트 상세 |
| 기준년 |
2022년 |
2023년 시장 규모 |
12억 8,090만 달러 |
| 실적 데이터 |
2018-2021년 |
예측 기간 |
2023-2030 |
| 예측 기간 CAGR |
3.70% |
2030년 시장 규모 예측 |
16억 5,180만 달러 |
세계의 박테리오파지 요법 시장 점유율(%), 제품 유형별, 2023년
파지는 공식적으로 박테리오파지로 알려져 있으며, 박테리아만 죽이고 선택적으로 박테리아를 표적으로 삼는 바이러스입니다. 파지는 다제내성 박테리아를 효과적으로 퇴치하고 파괴할 수 있는 가장 흔한 생물학적 존재 중 하나입니다. 모든 항생제가 감염에 효과가 없을 때, 파지는 감염을 일으키는 박테리아를 죽일 수 있으므로 의료진이 생명을 구할 수 있습니다. 박테리오파지는 항생제를 대체할 수 있는 새로운 치료법으로 검토되고 있습니다. 이 치료법은 바이러스가 박테리아에 유전물질을 주입하고 숙주의 기계를 이용해 자가 증식하는 방식입니다. 이 파지 요법은 환자의 체내 세균 감염을 치료하거나 예방하는 데 사용됩니다. 박테리오파지 치료는 분자생물학 및 생명공학 연구 분야에서도 중요한 역할을 하고 있습니다. 이러한 요인으로 인해 신약 개발의 가능성이 확대되고 있습니다.
시장 역학
주요 업체들 시장 포트폴리오를 확대하기 위한 규제 당국의 제품 승인과 같은 유기적 성장 전략 증가는 예측 기간 중 시장 성장을 가속할 것으로 예상됩니다. 예를 들어 2021년 9월, 감염성 질환 치료제를 전문적으로 제공하는 임상 단계의 생명공학 기업 Adaptive Phage Therapeutics, Inc. Adaptive Phage Therapeutics, Inc.는 APT의 파지뱅크 플랫폼이 여러 적응증에 걸쳐 약물 내성 감염을 치료하는 데 도움이 될 수 있고, 국가 군인의 생명을 구할 수 있는 잠재력을 가지고 있다고 밝혔다, 군인들의 생명을 구할 수 있는 치료법을 개발할 수 있게 되어 기쁘게 생각한다고 밝혔습니다.
본 조사의 주요 특징
- 이 조사 리포트는 세계의 박테리오파지 요법 시장을 상세 분석하고, 2022년을 기준년으로 한 예측 기간(2023-2030년)의 시장 규모 및 연간 평균 성장률(CAGR)을 제공합니다.
- 또한 다양한 부문의 잠재적 매출 기회를 설명하고, 이 시장에 대한 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 주요 인사이트도 제공하고 있습니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터에 기반하여 세계의 박테리오파지 요법 시장의 주요 기업을 프로파일링하고 있습니다.
- 본 리포트로부터의 인사이트는 마케팅 담당자나 기업의 경영진이 향후 제품 발매, 유형 업, 시장 확대, 마케팅 전술에 관한 정보에 기반한 의사결정을 시행하는 것을 가능하게 합니다.
- 박테리오파지 요법 세계 시장 리포트는 투자자, 공급업체, 제품 제조업체, 판매업체, 신규 참여업체, 재무 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 하고 있습니다.
- 세계의 박테리오파지 요법 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 이해관계자는 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제
제2장 시장 전망
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 최근 테스트 발사
- 역학
- 합병, 인수 및 협업
- 규제 시나리오
- 주요 발전
- PEST 분석
제4장 세계의 박테리오파지 요법 시장, COVID-19의 영향 분석
- 경제적 영향
- 신종 코로나바이러스(COVID-19)의 역학
- 수요와 공급에 대한 영향
제5장 세계의 박테리오파지 요법 시장, 표적 세균별, 2018-2030년
- 대장균
- 황색포도상구균
- 황색포도상구균
- 연쇄구균
- 녹농균
- 살모넬라균
- 기타
제6장 세계의 박테리오파지 치료 시장, 적응 질환별, 2018-2030년
- 요로감염증
- 만성 중이염
- 발치
- 만성 궤양성 대장염
- 뼈감염증
- 창상과 피부 감염증
- 낭포성섬유증
- 기타
제7장 세계의 박테리오파지 요법 시장, 투여 경로별, 2018-2030년
제8장 세계의 박테리오파지 요법 시장, 유통 채널별, 2018-2030년
제9장 세계의 박테리오파지 요법 시장, 지역별, 2018-2030년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 중동
- GCC
- 이스라엘
- 기타 중동
- 아프리카
- 북아프리카
- 중앙아프리카
- 남아프리카공화국
제10장 경쟁 구도
- 기업 개요
- Armata Pharmaceuticals, Inc.
- Eliava Biopreparations Ltd
- Pherecydes Pharma
- Intralytix, Inc.
- Phagelux, Inc.
- Intralytix, Inc.
- Nextbiotics
- InnoPhage, Ltd
- Locus Biosciences, Inc.
- TechnoPhage
- Eligo Bioscience SA
- Phagomed Biopharma GmbH
- PhagePro, Inc.
- Adaptive Phage Therapeutics
- Enbiotix, Inc
- Intodeworld, Inc.
- BiomX Ltd.
- Phi Therapeutics
- Fixed-phage Ltd
- Micreos BV
- ContraFect Corporation
- OPTIPHARM Co., Ltd.
제11장 섹션
KSA
영문 목차
The global bacteriophage therapy market is estimated to be valued at US$ 1,280.9 million in 2023 and is expected to exhibit a CAGR of 3.7% during the forecast period (2023-2030).
| Report Coverage |
Report Details |
| Base Year: |
2022 |
Market Size in 2023: |
US$ 1,280.9 Mn |
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: |
3.70% |
2030 Value Projection: |
US$ 1,651.8 Mn |
Global Bacteriophage Therapy Market Share (%), By Product Type, 2023
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are one of the most common biological entities that can effectively fight and destroy multi-drug-resistant bacteria. When all antibiotics fail to work against an infection, the phages are able to kill the bacteria causing the infection, thus helping medical professionals save life. Bacteriophages are being considered as a new alternative to antibiotics. In this therapy, the viruses are used to inject their genetic material into bacteria and use their host machinery to multiply themselves. This phage therapy is used to treat or prevent bacterial infections in patients' bodies. Bacteriophage therapy also plays a significant role in the research fields of molecular biology and biotechnology. These factors enhance the potential scope for drug discovery.
Market Dynamics
The increasing organic growth strategies, such as product approval by regulatory authorities to expand key players market portfolio, are expected to drive market growth over the forecast period. For instance, in September 2021, Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, announced that the Department of Defense (DoD), an executive branch department of the federal government of the U.S., had awarded the company an additional US$8 million for the continued development of bacteriophage therapies (APT's phage bankTM) for the treatment of infectious diseases. Adaptive Phage Therapeutics, Inc. said that it is thrilled APT's phage bank platform helps to treat drug-resistant infections across multiple indications that create potentially lifesaving therapies for the nation's service members.
Key features of the study:
- This report provides an in-depth analysis of the global bacteriophage therapy market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global bacteriophage therapy market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux, Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Enbiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation, OPTIPHARM Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global Bacteriophage Therapy Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacteriophage therapy market.
Detailed Segmentation:
- Global Bacteriophage Therapy Market, By Targeted Bacteria:
- Escherichia coli
- Staphylococcus aureus
- Streptococcus
- Pseudomonas aeruginosa
- Salmonella
- Others
- Global Bacteriophage Therapy Market, By Disease Indication:
- Urinary Tract Infections
- Chronic Otitis
- Dental Extraction
- Chronic Ulcerative Colitis
- Bone Infection
- Wound and Skin Infections
- Cystic Fibrosis
- Others
- Global Bacteriophage Therapy Market, By Route of Administration:
- Global Bacteriophage Therapy Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Bacteriophage Therapy Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Armata Pharmaceuticals, Inc.
- Eliava Biopreparations Ltd.
- Pherecydes Pharma
- Intralytix, Inc.
- Phagelux, Inc.
- Nextbiotics
- InnoPhage, Ltd
- Locus Biosciences, Inc.
- TechnoPhage
- Eligo Bioscience SA
- Phagomed Biopharma GmbH.
- PhagePro, Inc.
- Adaptive Phage Therapeutics
- Enbiotix, Inc.
- Intodeworld, Inc.
- BiomX Ltd.
- Phi Therapeutics
- Fixed-phage Ltd.
- Micreos BV
- ContraFect Corporation
- OPTIPHARM Co., Ltd.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Targeted Bacteria
- Market Snippet, By Disease Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Bacteriophage Therapy Market, - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Bacteriophage Therapy Market, By Targeted Bacteria, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Escherichia coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Staphylococcus aureus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Staphylococcus aureus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Streptococcus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Pseudomonas aeruginosa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Salmonella
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
6. Global Bacteriophage Therapy Market, By Disease Indication, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Chronic Otitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Dental Extraction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Chronic Ulcerative Colitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Bone Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Wound and Skin Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Cystic Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
7. Global Bacteriophage Therapy Market, By Route of Administration, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
8. Global Bacteriophage Therapy Market, By Distribution Channel, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
9. Global Bacteriophage Therapy Market, By Region, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Armata Pharmaceuticals, Inc. *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Eliava Biopreparations Ltd
- Pherecydes Pharma
- Intralytix, Inc.
- Phagelux, Inc.
- Intralytix, Inc.
- Nextbiotics
- InnoPhage, Ltd
- Locus Biosciences, Inc.
- TechnoPhage
- Eligo Bioscience SA
- Phagomed Biopharma GmbH
- PhagePro, Inc.
- Adaptive Phage Therapeutics
- Enbiotix, Inc
- Intodeworld, Inc.
- BiomX Ltd.
- Phi Therapeutics
- Fixed-phage Ltd
- Micreos BV
- ContraFect Corporation
- OPTIPHARM Co., Ltd.
11. Section
- References
- Research Methodology
- About us and Sales Contact
관련자료
